Edesa Biotech, Inc. announced that on February 28, 2022, Peter van der Velden notified the Board of Directors (the Board) of Edesa Biotech, Inc. (the Company) of his decision to resign from the Board and its committees, effective as of February 28, 2022. Mr. van der Velden had been on the Board since 2015 and the resignation is in line with normal course activities of his firm which remains an investor in the Company. His departure is not the result of any disagreement with the Company regarding its operations, policies or procedures.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.53 USD | +2.14% | +0.22% | -0.88% |
May. 10 | Edesa Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
Mar. 05 | Top Premarket Gainers | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.88% | 14.26M | |
+5.15% | 111B | |
+12.15% | 105B | |
-12.87% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-11.28% | 16.96B | |
+4.79% | 13.7B | |
+36.61% | 12.45B |
- Stock Market
- Equities
- EDSA Stock
- News Edesa Biotech, Inc.
- Edesa Biotech, Inc. Announces Peter Van Der Velden Resign from Board and Its Committees